RAPH
Raphael Pharmaceutical Inc.Company with tickers: RAPH
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-11-20 | Louria Hayon Igal |
Director, Chief Technology Officer | Exercise | 350,000 |
| 2025-11-20 | Louria Hayon Igal |
Director, Chief Technology Officer | Exercise | 350,000 |
| 2025-08-01 | Laor Zvi Laufer |
Director | Other | 0 |
| 2025-03-10 | Eliya Yehuda |
Director | Award | 200,000 |
| 2025-03-05 | Dhadha Ajay Kumar |
Director | Award | 250,000 |
| 2025-03-05 | Dhadha Ajay Kumar |
Director | Award | 350,000 |
| 2025-03-02 | Pilo Shlomo |
Director, Chief Executive Officer, 10% Owner | Award | 200,000 |
| 2025-03-02 | Pilo Shlomo |
Director, Chief Executive Officer, 10% Owner | Award | 100,000 |
| 2023-11-25 | Eliya Yehuda |
Director | Award | 150,000 |
| 2023-08-29 | Louria Hayon Igal |
Director, Chief Technology Officer | Exercise | 999,000 |
| 2023-08-29 | Louria Hayon Igal |
Director, Chief Technology Officer | Exercise | 999,000 |
| 2022-12-05 | Eliya Yehuda |
Director | Award | 202,000 |
| 2022-12-05 | Pilo Shlomo |
Director, Chief Executive Officer, 10% Owner | Award | 1,000,000 |
| 2022-12-05 | Ofir Guy |
Director, Chief Financial Officer | Award | 1,000,000 |
| 2022-12-05 | Press Joseph |
Director | Award | 105,000 |
| 2022-12-05 | Louria Hayon Igal |
Director, Chief Technology Officer | Award | 999,000 |
| 2022-07-26 | Press Joseph |
Director | Award | 280,000 |
| 2022-07-26 | Ofir Guy |
Director, Chief Financial Officer | Award | 1,000,000 |
| 2022-05-12 | Eliya Yehuda |
Director | Expiration | 202,000 |
| 2021-09-27 | Louria Hayon Igal |
Director, Chief Technology Officer | Other | 0 |
| 2021-09-27 | Eliya Yehuda |
Director | Other | 0 |
| 2021-09-27 | Press Joseph |
Director | Other | 0 |
Showing 1–22 of 22 transactions